Obach R S, van Vunakis H
Department of Biochemistry, Brandeis University, Waltham, MA 02254.
Drug Metab Dispos. 1990 Jul-Aug;18(4):508-13.
Cotinine, one of the major metabolites of nicotine, is formed by two sequential enzyme reactions: [formula: see text] Chemical and immunological methods of analysis are available to quantify these two compounds (I and III). Study of the intermediate (III) is hampered because of its complex chemistry and lack of simple methods for its assay. Generally, (II) is trapped by addition of cyanide and analyzed as the 5'-cyanonicotine adduct. In order to develop an immunoassay for (II), rabbits were immunized with a 3'-succinylmethyl-5'-cyanonicotine-protein conjugate with the expectation that (II) would, after treatment with cyanide, be quantified as 5'-cyanonicotine. Unexpectedly, however, the antibodies recognized the cyano adduct and (II) to the same extent (limit of deletion = 1.2 pmol). Nicotine, cotinine, and several other metabolites do not significantly inhibit the antigen-antibody reaction. Inhibition studies with 5' substituted nicotine analogs indicate that the 5'-hydroxynicotine tautomer (IIb) is the species recognized by the antibodies. Inin vitro metabolic studies, (II) accumulates in the absence of aldehyde oxidase, but in its presence, is converted to cotinine. As judged by serological activity, dilute solutions (under 15 microM) of (II) are stable when allowed to stand for 6 days at pH 7 and 37 degrees C. However, at high concentrations of iminium ion (where NMR studies showed instability and formation of multiple products) serological activity is also lost. Iminium ions are generated during the metabolism of some tertiary amine xenobiotics. The use of alpha-cyanoamine haptens to elicit antibodies specific for iminium ions and/or their cyano adducts may permit development of immunoassays for these compounds.
可替宁是尼古丁的主要代谢产物之一,由两个连续的酶促反应形成:[化学式:见原文]。有化学和免疫分析方法可用于定量这两种化合物(I和III)。由于中间体(III)的化学性质复杂且缺乏简单的测定方法,对其研究受到阻碍。通常,通过加入氰化物捕获(II),并将其作为5'-氰基尼古丁加合物进行分析。为了开发针对(II)的免疫测定方法,用3'-琥珀酰甲基-5'-氰基尼古丁-蛋白质偶联物对兔子进行免疫,期望(II)在用氰化物处理后能作为5'-氰基尼古丁进行定量。然而,出乎意料的是,抗体对氰基加合物和(II)的识别程度相同(检测限 = 1.2皮摩尔)。尼古丁、可替宁和其他几种代谢产物不会显著抑制抗原-抗体反应。用5'取代的尼古丁类似物进行的抑制研究表明,5'-羟基尼古丁互变异构体(IIb)是抗体识别的物质。在体外代谢研究中,(II)在没有醛氧化酶的情况下会积累,但在其存在时会转化为可替宁。根据血清学活性判断,(II)的稀溶液(低于15微摩尔)在pH 7和37℃下放置6天时是稳定的。然而,在高浓度的亚胺离子存在下(核磁共振研究表明此时不稳定并形成多种产物),血清学活性也会丧失。亚胺离子是在某些叔胺外源性物质的代谢过程中产生的。使用α-氰基胺半抗原引发对亚胺离子和/或其氰基加合物具有特异性的抗体,可能有助于开发针对这些化合物的免疫测定方法。